Summary & Overview
HCPCS G8450: Beta-blocker Therapy Prescribed
HCPCS Level II code G8450 denotes the prescription of beta-blocker therapy, a common class of medications used in cardiovascular care and other clinical contexts. As a billing indicator, this code flags when a provider prescribes a beta-adrenergic blocker and is relevant for documenting quality measures, medication management, and care coordination nationally. Its use supports tracking of pharmacologic therapy and aligns with clinical efforts to document guideline-directed treatments.
Key payers in the national discussion include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise framing of clinical context for beta-blocker prescribing, alongside the payer landscape covered in the analysis. The publication outlines expected benchmarks, coding practice considerations, and policy or coverage nuances affecting billing and documentation. Practical elements covered include typical sites of service and the codes role in medication management documentation.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and detailed payer-specific coverage rules. The content is intended to clarify what G8450 represents and what readers will learn about its clinical and billing significance on a national level.
Billing Code Overview
HCPCS Level II code G8450 represents beta-blocker therapy prescribed. This code is used to indicate the prescription of a beta-adrenergic blocking agent as part of patient care.
Service type: Medication management / prescription of beta-blocker therapy
Typical site of service: Outpatient clinic or ambulatory care setting where prescriptions are written or medication management is documented.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with a history of hypertension and prior myocardial infarction presents to primary care for longitudinal management after hospital discharge. The clinician documents initiation of a beta-blocker as part of secondary prevention and blood pressure control. The workflow includes medication reconciliation, assessment of contraindications (e.g., bradycardia, heart block, decompensated heart failure, reactive airway disease), counseling on expected effects and adverse events, documentation of the prescription in the electronic health record, and electronic or paper transmission of the prescription to the patient’s pharmacy. Typical monitoring includes follow-up blood pressure and heart rate checks within 1–2 weeks and medication tolerance assessment at subsequent visits.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when unusually high clinical effort related to counseling or complex medication management is documented and meets payer criteria for increased services. |
23 | Unusual anesthesia | Not typically used for medication prescription; include only if anesthesia-related services are separately reported. |